组织学特征对肝硬化临床终点事件的预测

张梦阳; 孙亚朦

doi:10.3969/j.issn.1001-5256.2020.09.003

组织学特征对肝硬化临床终点事件的预测

DOI: 10.3969/j.issn.1001-5256.2020.09.003

首都医科大学附属北京友谊医院肝病中心

基金项目:

国家科技重大专项(2018ZX10302204,2018ZX10302204-004)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1189
- HTML全文浏览量: 41
- PDF下载量: 116
- 被引次数: 0
出版历程
- 收稿日期: 2020-05-05
- 出版日期: 2020-09-20

Histological prediction of clinical endpoints of liver cirrhosis

Liver Research Center,Beijing Friendship Hospital,Capital Medical University

Research funding:

摘要

摘要: 肝硬化患者的临床表现及预后具有较大差异,准确预测肝硬化临床终点事件十分必要。肝脏病理可直观反映组织结构及其变化,在预测终点事件中有重要价值。总结了肝硬化组织学评价体系及组织学参数在预测临床终点事件中的应用,同时描述了病因治疗后的肝硬化组织学特点对临床预后的预测意义。
- 肝硬化 /
- 活组织检测,针吸 /
- 预后
Abstract: Patients with liver cirrhosis have different clinical manifestations and prognoses,and it is necessary to accurately predict the clinical endpoints of liver cirrhosis. Liver pathology can directly display the change in liver structure and thus plays an important role in predicting clinical endpoints. This article summarizes the application of histological staging systems and parameters in predicting clinical endpoints and describes the significance of histological features after etiological treatment in predicting clinical prognosis.
- liver cirrhosis /
- biopsy,needle /
- prognosis

HTML全文

参考文献(27)

[1] GARCIA-TSAO G,FRIEDMAN S,IREDALE J,et al. Now there are many(stages)where before there was one:In search of a pathophysiological classification of cirrhosis[J].Hepatology,2010,51(4):1445-1449.

[2] RODRGUEZ-DAZ JL,ROSAS-CAMARGO V,VEGA-VEGA O,et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis:A long-term follow-up study[J]. Clin Oncol(R Coll Radiol),2007,19(3):197-203.

[3] KIM MY,CHO MY,BAIK SK,et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension[J].J Hepatol,2011,55(5):1004-1009.

[4] KIM G,LEE SS,BAIK SK,et al. The need for histological subclassification of cirrhosis:A systematic review and meta-analysis[J]. Liver Int,2016,36(6):847-855.

[5] WANG W,LI J,PAN R,et al. Association of the Laennec staging system with degree of cirrhosis,clinical stage and liver function[J]. Hepatol Int,2015,9(4):621-626.

[6] KIM SU,OH HJ,WANLESS IR,et al. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis[J].J Hepatol,2012,57(3),556-563.

[7] KIM SU,JUNG KS,LEE S,et al. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma[J]. Liver Int,2014,34(7):1008-1017.

[8] NAGULA S,JAIN D,GROSZMANN RJ,et al. Histologicalhemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis[J]. J Hepatol,2006,44(1):111-117.

[9] RIPOLL C,GROSZMANN RJ,GARCIA-TSAO G,et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis[J].J Hepatol,2009,50(5):923-928.

[10] RIPOLL C,GROSZMANN R,GARCIA-TSAO G,et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis[J]. Gastroenterology,2007,133(2):481-488.

[11] ROSKAMS T,BAPTISTA A,BIANCHI L,et al. Histopathology of portal hypertension:Apractical guideline[J]. Histopathology,2003,42(1):2-13.

[12] WU QM,ZHAO XY,YOU H. Quantitative fibrosis parameters highly predict esophageal-gastro varices in primary biliary cirrhosis[J]. Eur Rev Med Pharmacol Sci,2016,20(6):1037-1043.

[13] XU S,WANG Y,TAI DCS,et al. qFibrosis:A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J]. J Hepatol,2014,61(2):260-269.

[14] CALVARUSO V,BURROUGHS AK,STANDISH R,et al. Computer-assisted image analysis of liver collagen:Relationship to Ishak scoring and hepatic venous pressure gradient[J].Hepatology,2009,49(4):1236-1244.

[15] MANOUSOU P,DHILLON AP,ISGRO G,et al. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation[J]. Liver Transpl,2011,17(2):178-188.

[16] TSOCHATZIS E,BRUNO S,ISGRO G,et al. Col agen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis[J]. J Hepatol,2014,60(5):948-954.

[17] MANOUSOU P,BURROUGHS AK,TSOCHATZIS E,et al.Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation[J]. J Hepatol,2013,58(5):962-968.

[18] CO爦AR AM,YAKAR T,SERIN E,et al. The relationship between fibrosis and nodule structure and esophageal varices[J]. Turk J Gastroenterol,2019,30(7):624-629.

[19] van LEEUWEN DJ,HOWE SC,SCHEUER PJ,et al. Portal hypertension in chronic hepatitis:Relationship to morphological changes[J]. Gut,1990,31(3):339-343.

[20] COLMAN JC,BRITTON RS,ORREGO H,et al. Relation between osmotically induced hepatocyte enlargement and portal hypertension[J]. Am J Physiol,1983,245(3):g382-g387.

[21] BLENDIS LM,ORREGO H,CROSSLEY IR,et al. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease[J]. Hepatology,1982,2(5):539-546.

[22] DONATO MF,AROSIO E,DEL NINNO E,et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity[J]. Hepatology,2001,34(3):523-528.

[23] ZHOU P,XIA J,ZHOU YJ,et al. Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients[J]. World J Gastroenterol,2015,21(21):6665-6674.

[24] SUN Y,ZHOU J,WANG L,et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology,2017,65(5):1438-1450.

[25] LEE HW,NA K,KIM SU,et al. Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy[J]. Sci Rep,2019,9(1):15628.

[26] BEDOSSA P. Reversibility of hepatitis B virus cirrhosis after therapy:Who and why?[J]. Liver Int,2015,35(Suppl 1):78-81.

[27] FLEMING KE,WANLESS IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis[J]. Liver Int,2013,33(4):525-534.

施引文献

资源附件(0)

访问统计